# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-23-000428
Filing Date
2023-03-30
Accepted
2023-03-30 08:16:57
Documents
92
Period of Report
2022-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | tmb-20221231x10k.htm iXBRL | 10-K | 4631901
2 | EX-4.4 | tmb-20221231xex4d4.htm | EX-4.4 | 23716
3 | EX-21.1 | tmb-20221231xex21d1.htm | EX-21.1 | 13357
4 | EX-23.1 | tmb-20221231xex23d1.htm | EX-23.1 | 5362
5 | EX-31.1 | tmb-20221231xex31d1.htm | EX-31.1 | 13668
6 | EX-32.1 | tmb-20221231xex32d1.htm | EX-32.1 | 8654
7 | GRAPHIC | tmb-20221231x10k001.jpg | GRAPHIC | 46974
8 | GRAPHIC | tmb-20221231x10k002.jpg | GRAPHIC | 54975
| Complete submission text file | 0001410578-23-000428.txt |  | 21247411

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | EX-101.SCH | tmb-20221231.xsd | EX-101.SCH | 82321
10 | EX-101.CAL | tmb-20221231_cal.xml | EX-101.CAL | 71272
11 | EX-101.DEF | tmb-20221231_def.xml | EX-101.DEF | 454608
12 | EX-101.LAB | tmb-20221231_lab.xml | EX-101.LAB | 598442
13 | EX-101.PRE | tmb-20221231_pre.xml | EX-101.PRE | 650390
86 | EXTRACTED XBRL INSTANCE DOCUMENT | tmb-20221231x10k_htm.xml | XML | 5579290

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12584 | Film No.: 23777249
SIC: 2834 Pharmaceutical Preparations